In Vitro Sensitivity of Plasmodium falciparum Clinical Isolates from the China-Myanmar Border Area to Quinine and Association with Polymorphism in the Na + /H + Exchanger

Antimicrobial Agents and Chemotherapy
2010.0

Abstract

Quinine resistance (QNR) in Plasmodium falciparum has been detected in many regions of the world where malaria is endemic. Genetic polymorphisms in at least four genes are implicated in QN susceptibility, and their significance often depends on the genetic background of the parasites. In this study, we have culture-adapted 60 P. falciparum clinical isolates from the China-Myanmar border and assessed their in vitro responses to QN. Our results showed that >50% of the parasite isolates displayed reduced sensitivity to QN, with a half-maximal inhibitory concentration (IC(50)) above 500 nM. Genotyping of pfcrt found that an overwhelming proportion of the parasite population had the chloroquine-resistant genotype, whereas pfmdr1 mutation genotypes and gene amplification were rare. Genotyping of the P. falciparum Na(+)/H(+) exchanger gene (pfnhe1) at the minisatellite ms4760 locus identified 10 haplotypes. Haplotype 7, which harbors three copies of the DNNND repeat, was the most predominant, accounting for nearly half of the parasite isolates. Correlation studies did not reveal significant associations of the polymorphisms in pfcrt and pfmdr1 genes with QN response. However, the ms4760 haplotypes were highly associated with in vitro QN responses. In particular, parasite isolates with an increased DNNND copy number tended to have significantly reduced QN susceptibility, whereas parasite isolates with a higher NHNDNHNNDDD copy number had increased QN susceptibility. This study provided further support for the importance of pfnhe1 polymorphisms in influencing QNR in P. falciparum.

Knowledge Graph

Similar Paper

In Vitro Sensitivity of Plasmodium falciparum Clinical Isolates from the China-Myanmar Border Area to Quinine and Association with Polymorphism in the Na <sup>+</sup> /H <sup>+</sup> Exchanger
Antimicrobial Agents and Chemotherapy 2010.0
Plasmodium falciparumNa<sup>+</sup>/H<sup>+</sup>Exchanger 1 Transporter Is Involved in Reduced Susceptibility to Quinine
Antimicrobial Agents and Chemotherapy 2009.0
In Vitro Activities of Quinine and Other Antimalarials and pfnhe Polymorphisms in Plasmodium Isolates from Kenya
Antimicrobial Agents and Chemotherapy 2010.0
Absence of Association between Piperaquine In Vitro Responses and Polymorphisms in the pfcrt , pfmdr1 , pfmrp , and pfnhe Genes in Plasmodium falciparum
Antimicrobial Agents and Chemotherapy 2010.0
In Vitro Sensitivities of Plasmodium falciparum to Different Antimalarial Drugs in Uganda
Antimicrobial Agents and Chemotherapy 2010.0
In Vitro Activities of Piperaquine, Lumefantrine, and Dihydroartemisinin in Kenyan Plasmodium falciparum Isolates and Polymorphisms in p fcrt and p fmdr1
Antimicrobial Agents and Chemotherapy 2009.0
Plasmodium falciparumDrug Resistance in Madagascar: Facing the Spread of Unusualpfdhfrandpfmdr-1Haplotypes and the Decrease of Dihydroartemisinin Susceptibility
Antimicrobial Agents and Chemotherapy 2009.0
Investigating the activity of quinine analogues versus chloroquine resistant Plasmodium falciparum
Bioorganic &amp; Medicinal Chemistry 2012.0
Role of Known Molecular Markers of Resistance in the Antimalarial Potency of Piperaquine and Dihydroartemisinin In Vitro
Antimicrobial Agents and Chemotherapy 2009.0
Genetic Analysis of the Dihydrofolate Reductase-Thymidylate Synthase Gene from Geographically Diverse Isolates of Plasmodium malariae
Antimicrobial Agents and Chemotherapy 2007.0